It was an early proof-of-concept trial with about 32 people who completed it, so the results are promising but preliminary (Depommier et al., 2019)
Theyre experiencing some serious changes, and not all of them are necessarily positive
Their neglect has often resulted from early adverse events attributable to poor pharmacokinetic design, incomplete receptor mapping, or the absence of enabling technologies now considered routine, such as long-acting peptide conjugation, tissue-selective targeting, and signal-bias optimization
SIRT3 also deacetylates targets such as the chaperone protein Hsp10 and the LON protease, involved in the UPR mt process 98
B12 shots are highly effective It helps treat some issues, improve mood, and even boost energy levels